Lithium Carbonate Tablet, Extended Release
Product Images NDC 70518-2086

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 70518-2086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Lithium Carbonate extended-release tablets, manufactured by Rising Pharma, Inc. in Allendale, NJ. Each tablet contains 450 mg of the active ingredient. The lot number and NDC are provided for reference. The medication is in tablet form and is sold in quantities of 30. Storage instructions are given to maintain potency. Directions for use are contained in the package insert. No information is provided about the medical indication of Lithium Carbonate.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.